KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Cash from Investing Activities (2016 - 2025)

Resmed (RMD) has disclosed Cash from Investing Activities for 17 consecutive years, with -$50.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 38.84% year-over-year to -$50.9 million, compared with a TTM value of -$269.0 million through Dec 2025, down 135.55%, and an annual FY2025 reading of -$200.0 million, up 25.85% over the prior year.
  • Cash from Investing Activities was -$50.9 million for Q4 2025 at Resmed, up from -$52.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.1 million in Q3 2024 and bottomed at -$1.0 billion in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$103.5 million, with a median of -$48.8 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities surged 101.44% in 2024, then plummeted 2550.05% in 2025.
  • Year by year, Cash from Investing Activities stood at -$83.3 million in 2021, then plummeted by 1132.07% to -$1.0 billion in 2022, then soared by 95.99% to -$41.1 million in 2023, then increased by 10.82% to -$36.7 million in 2024, then plummeted by 38.84% to -$50.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RMD at -$50.9 million in Q4 2025, -$52.6 million in Q3 2025, and -$133.7 million in Q2 2025.